{"id":"W2247100049","doi":"10.1200/jco.2006.24.18_suppl.2014","title":"Phase 1 study of CPX-1, a fixed ratio formulation of irinotecan (IRI) and floxuridine (FLOX), in patients with advanced solid tumors","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Celator Pharmaceuticals (Canada); Jewish General Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacokinetics; Response Evaluation Criteria in Solid Tumors; Internal medicine; Urology; Cohort; Phases of clinical research; Gastroenterology; Oncology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009817497,0.001402126,0.00153875,0.0005566452,0.0004853603,0.0006850149,0.0006644258,0.001050783,0.003527005],"category_scores_gemma":[0.0005792721,0.0006518441,0.0007949015,0.0003057288,0.0007730386,0.0007336351,0.0003357418,0.002792124,0.0007868074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009982621,"about_ca_system_score_gemma":0.001642454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009086074,"about_ca_topic_score_gemma":0.001560663,"domain_scores_codex":[0.9997049,0.0001037674,0.00001206984,0.00007837005,0.00003957264,0.00006135341],"domain_scores_gemma":[0.9996672,0.00004481459,0.00005368107,0.00002898753,0.00003017347,0.0001752524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4299295,0.2432512,0.01443018,0.001036084,0.0009164239,0.0009351534,0.0008955753,0.005019333,0.1760198,0.0005648602,0.005908788,0.1210932],"study_design_scores_gemma":[0.1588109,0.8140432,0.01285565,0.00002009118,0.0002152717,0.0004839713,0.00006974854,0.001304702,0.009285472,0.0001147054,0.002774636,0.00002171753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995208,0.0005961829,0.0003597043,0.0001673623,0.00004760445,0.002423115,0.0004422677,0.00004772728,0.0007079841],"genre_scores_gemma":[0.9912264,0.0007428523,0.001510916,0.0003300771,0.00008212352,0.002438202,0.001103618,0.000020276,0.002545609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003527005,"threshold_uncertainty_score":0.01179904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0319254875081656,"score_gpt":0.4006621124109691,"score_spread":0.3687366249028035,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}